XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net loss $ (5,261) $ (37,383) $ (15,475) $ (48,235)
Available for sale securities - net unrealized gain 0 5 1 5
Cumulative translation adjustment arising during the period (50) (25) (72) (25)
Total other comprehensive loss (50) (20) (71) (20)
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (5,311) $ (37,403) $ (15,546) $ (48,255)